Free Trial
NASDAQ:HYPR

Hyperfine (HYPR) Stock Price, News & Analysis

Hyperfine logo
$0.76 -0.02 (-2.47%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$0.78 +0.02 (+2.38%)
As of 04/25/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Hyperfine Stock (NASDAQ:HYPR)

Key Stats

Today's Range
$0.75
$0.79
50-Day Range
$0.61
$1.28
52-Week Range
$0.58
$1.90
Volume
104,683 shs
Average Volume
382,744 shs
Market Capitalization
$58.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.33
Consensus Rating
Moderate Buy

Company Overview

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

Hyperfine Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

HYPR MarketRank™: 

Hyperfine scored higher than 63% of companies evaluated by MarketBeat, and ranked 258th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hyperfine has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Hyperfine has only been the subject of 3 research reports in the past 90 days.

  • Read more about Hyperfine's stock forecast and price target.
  • Earnings Growth

    Earnings for Hyperfine are expected to grow in the coming year, from ($0.57) to ($0.53) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hyperfine is -1.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hyperfine is -1.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Hyperfine has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Hyperfine's valuation and earnings.
  • Percentage of Shares Shorted

    4.11% of the float of Hyperfine has been sold short.
  • Short Interest Ratio / Days to Cover

    Hyperfine has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hyperfine has recently increased by 33.71%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Hyperfine does not currently pay a dividend.

  • Dividend Growth

    Hyperfine does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.11% of the float of Hyperfine has been sold short.
  • Short Interest Ratio / Days to Cover

    Hyperfine has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hyperfine has recently increased by 33.71%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Hyperfine has a news sentiment score of 1.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Hyperfine this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Hyperfine insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,884.00 in company stock.

  • Percentage Held by Insiders

    30.98% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.03% of the stock of Hyperfine is held by institutions.

  • Read more about Hyperfine's insider trading history.
Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

HYPR Stock News Headlines

Hyperfine enrolls initial patients in NEURO PMR study
Donald Trump is about to free crypto from its chains …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.
Hyperfine initiated with a Buy at Lake Street
Hyperfine price target lowered to $1.20 from $1.50 at B. Riley
See More Headlines

HYPR Stock Analysis - Frequently Asked Questions

Hyperfine's stock was trading at $0.88 at the beginning of the year. Since then, HYPR shares have decreased by 14.0% and is now trading at $0.7570.
View the best growth stocks for 2025 here
.

Hyperfine, Inc. (NASDAQ:HYPR) posted its quarterly earnings results on Monday, March, 17th. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.02. The firm had revenue of $2.32 million for the quarter, compared to the consensus estimate of $2.30 million. Hyperfine had a negative trailing twelve-month return on equity of 57.54% and a negative net margin of 309.42%.
Read the conference call transcript
.

Top institutional investors of Hyperfine include Wealth Enhancement Advisory Services LLC (0.07%). Insiders that own company stock include Jonathan M Rothberg, Alok Gupta, Neela Paykel, Thomas Teisseyre and Khan Siddiqui.
View institutional ownership trends
.

Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hyperfine investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Paycom Software (PAYC), Adobe (ADBE) and Jabil (JBL).

Company Calendar

Last Earnings
3/17/2025
Today
4/26/2025
Next Earnings (Estimated)
5/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:HYPR
Fax
N/A
Employees
190
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.33
High Stock Price Target
$1.50
Low Stock Price Target
$1.20
Potential Upside/Downside
+75.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-44,240,000.00
Net Margins
-309.42%
Pretax Margin
-309.42%

Debt

Sales & Book Value

Annual Sales
$12.89 million
Price / Cash Flow
N/A
Book Value
$1.17 per share
Price / Book
0.65

Miscellaneous

Free Float
51,487,000
Market Cap
$58.92 million
Optionable
Optionable
Beta
1.05
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:HYPR) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners